Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Cutaquig
DRUG
2 trials
Sponsors
Octapharma
, Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Conditions
Primary Immune Deficiency Disorder
Primary Immunodeficiency Diseases (PID)
Phase 3
Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
Completed
NCT03939533
Octapharma
Primary Immune Deficiency Disorder
Start: 2019-10-17
End: 2022-01-03
Updated: 2023-11-07
Unknown Phase
Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies
NCT05986734
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Primary Immunodeficiency Diseases (PID)
Start: 2022-09-01
End: 2023-12-01
Target: 100
Updated: 2023-08-14